PROACT: a phase II randomized trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke. PROACT Investigators. Prolyse in Acute Cerebral Thromboembolism.

Source:http://linkedlifedata.com/resource/pubmed/id/9445320

Download in:

View as

General Info

PMID
9445320